OBSCN靶向药基因

基因名称:OBSCN  (obscurin, cytoskeletal calmodulin and titin-interacting RhoGEF)

别名: UNC89,ARHGEF30
基因ID:84033
Chromosome(GRCh37) :1 Start: 228395740 End: 228566577 Strand:
信号通路:
靶向药:
化疗药:

简介:蒙脱石基因跨越150 kb以上,含有超过80个外显子,编码约720 kDa的蛋白质。编码蛋白包含68个ig结构域、2个纤维连接蛋白结构域、1个钙/钙调素结合结构域、1个rhogef结构域和2个丝氨酸苏氨酸激酶结构域。该蛋白属于包括Titin和Nebulin在内的巨大骶节信号蛋白家族,可能在肌原纤维的组装过程中起作用,并可能介导肌浆网和肌原纤维之间的相互作用。另外,还发现了编码不同亚型的剪接转录变体。[由RefSeq提供,2008年7月]The obscurin gene spans more than 150 kb, contains over 80 exons and encodes a protein of approximately 720 kDa. The encoded protein contains 68 Ig domains, 2 fibronectin domains, 1 calcium/calmodulin-binding domain, 1 RhoGEF domain with an associated PH domain, and 2 serine-threonine kinase domains. This protein belongs to the family of giant sacromeric signaling proteins that includes titin and nebulin, and may have a role in the organization of myofibrils during assembly and may mediate interactions between the sarcoplasmic reticulum and myofibrils. Alternatively spliced transcript variants encoding different isoforms have been identified. [provided by RefSeq, Jul 2008]
OBSCN突变与药物:

常见问题
  • 如何在体龙基因完成所需的检测项目 流程简述 :在线咨询 - 采样送检 - 付款检测 - 检测分析 - 报告结果
查看详情

相关内容

官方客服团队

为您解决烦忧 - 24小时在线 专业服务